CORPORATION (OTCMKTS:CCYPQ) Files An 8-K Regulation FD Disclosure
Item7.01
| Regulation FD Disclosure. |
On March28, 2017, representatives of RXi Pharmaceuticals
Corporation participated in the 5th Annual Cancer BioPartnering
Investment Forum in New York, New York. A copy of the
presentation to be used during the conference is attached hereto
as Exhibit99.1 and is incorporated herein by reference.
The information in this Item 7.01 and attached as Exhibit 99.1 to
this Report will not be treated as filed for the purposes of
Section18 of the Securities Exchange Act of 1934, as amended (the
Exchange Act), or otherwise subject to the liabilities of that
section. This information will not be incorporated by reference
into any filing under the Securities Act of 1933, as amended, or
into another filing under the Exchange Act, unless that filing
expressly incorporates this information by reference.
| Item9.01 | Financial Statements and Exhibits. |
(d) Exhibits
| 99.1 | Conference Presentation, dated March28, 2017. |
* * *
2
CORPORATION (OTCMKTS:CCYPQ) Recent Trading Information
CORPORATION (OTCMKTS:CCYPQ) closed its last trading session 00.00000 at 0.00010 with 400 shares trading hands.
